Interleukin-2 (IL-2) Inhibitor Drug Pipeline Research Report 2024
March 05, 2024 03:30 ET
|
Research and Markets
Dublin, March 05, 2024 (GLOBE NEWSWIRE) -- The "Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
US HUMIRA Market Projected for Extensive Growth by 2032 in Noninfectious Autoimmune Uveitis Sector
February 28, 2024 11:05 ET
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "US HUMIRA Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. An insightful analysis...
Global Graft Versus Host Disease (GvHD) Treatment Market Forecast, 2028: High Treatment Costs and Infection Risks Prompt Focus on Predictive Biomarkers and Balanced Immunosuppression in Healthcare
January 26, 2024 09:10 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Graft vs. Host Disease Comprehensive 2032 Forecast Reveals Escalating Patient Populations in the 7MM
January 24, 2024 12:56 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This detailed analysis...
Liposomal Cyclosporine A Emerging Drug Insights and Market Forecasts, 2017-2023 & 2023-2032: Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
November 22, 2023 09:08 ET
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report...
Global Graft Versus Host Disease Treatment Market 2023-2030: Monoclonal Antibodies Lead Surge in Graft Versus Host Disease Treatment Market, Monitored by Comprehensive Vendor Analysis
September 13, 2023 06:54 ET
|
Research and Markets
Dublin, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Graft Versus Host Disease Treatment Market by Disease Type, Product, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
Adalimumab Global Market Report 2022: Rising Prevalence of Arthritis and Clinical Trials to Spur Growth
February 22, 2023 09:33 ET
|
Research and Markets
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Type (Biologics v/s Biosimilars), By...
Adalimumab, Infliximab And Etanercept Biosimilars Global Market Report 2023: Increasing Healthcare Access Bolsters Sector
January 11, 2023 04:48 ET
|
Research and Markets
Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031" report has been added to ...
Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2022: Featuring Zydus Cadila, Abbvie, Samsung Bioepis & More
November 18, 2022 08:08 ET
|
Research and Markets
Dublin, Nov. 18, 2022 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2022: By Product, By Application, By Distribution" report has been added to ...
Worldwide Reiter's Syndrome Treatment Industry to 2027 - by Drug Type, Dosage Form, Route of Administration, Distribution Channel, End-user and Region
September 28, 2022 06:38 ET
|
Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Reiter's Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027" report has been added to ...